Delivery Order SPE2DB20D3103-SPE2DB25FP7T9
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price arrangement. The contract, valued at $1,592.99, was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025. The award represents a non-competitive delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $1...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract valued at $17,313.29. The order, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical delivery. This delivery order is issued...
- The Defense Logistics Agency has awarded a delivery order valued at $18,417.70 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This competitively awarded, firm fixed-price contract was executed on July 23, 2025, with an ultimate completion date of July 24, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery order is...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract valued at $2,643.53. The award, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Jardiance 10 mg tablets in quantities of 90 units. This competitively awarded contract, valued at $34,528.08, represents a firm fixed-price delivery order with performance completion scheduled for August 28, 2025. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, and carries no set-aside designation. This delivery order is...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Jardiance 10mg tablets (90-count supply) valued at $4,893.30. This competitive, non-set-aside delivery order was awarded on September 13, 2025, with an ultimate completion date of October 9, 2025. AmerisourceBergen will perform this work at its corporate office location in Conshohocken, Pennsylvania. The contract employs firm fixed pricing under a delivery order structure,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract valued at $11,743.92, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for supply of Jardiance 10 mg tablets (90-count) with a firm fixed price ceiling value of $2,321.41. The contract, issued May 30, 2025, with an ultimate completion date of June 2, 2025, represents a non-competitive, competitively awarded delivery order under the company's larger pharmaceutical supply vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract valued at $15,289.31. The award, issued on June 2, 2025, with completion targeted for June 3, 2025, represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle. This delivery order was competitively awarded with no set-aside designation, and performance is based at the contractor's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) valued at $10,494.63. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP7T9Delivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $16,277.72. The contract was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement valued through December 2026 that serves as the company's primary vehicle for pharmaceutical and medical supply distribution to military healthcare systems globally. AmerisourceBergen Drug Corp, one of the nation's leading pharmaceutical distributors, has demonstrated substantial capability in meeting federal medical procurement requirements through competitive awards across multiple therapeutic domains. The company supplies an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency operations, U.S. Coast Guard, and other federal healthcare systems. This particular delivery order for Jardiance, an antidiabetic medication, reflects the company's ongoing role in supporting military and federal healthcare pharmaceutical needs through the DLA's comprehensive medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.3k | 8/7/25 |